Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints. [electronic resource]
Producer: 20031014Description: 229-34 p. digitalISSN:- 1078-1439
- Adenocarcinoma -- drug therapy
- Androgen Antagonists -- administration & dosage
- Androgens
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers
- Chemotherapy, Adjuvant
- Estramustine -- administration & dosage
- Flutamide -- administration & dosage
- Humans
- Leuprolide -- administration & dosage
- Male
- Neoadjuvant Therapy
- Neoplasms, Hormone-Dependent -- drug therapy
- Palliative Care
- Prostatectomy -- methods
- Prostatic Neoplasms -- drug therapy
- Randomized Controlled Trials as Topic -- methods
- Risk
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.